Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

34

Revenue 2017

Tivicay

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tivicay was produced by AbbVie and Eisai.

GSK starts recovery from China crisis as growth returns

GSK starts recovery from China crisis as growth returns Green lights for respiratory products Breo (fluticasone and vilanterol) and Anoro (umeclidinium and vilanterol); melanoma treatments Tafinlar (dabrafenib) and Mekinist (trametinib); and Tivicay (dolutegravir) for HIV - along with an expected

A new option for people with HIV

A new option for people with HIV The first global approval of dolutegravir (Tivicay) by the US Food and Drug Administration (FDA) in August 2013 resulted in a new option for millions of people with HIV-1 infection,

ViiV wins European approval for Tivicay

ViiV wins European approval for Tivicay HIV treatment licensed in combination with other anti-retroviral drugs. ViiV Healthcare's potential blockbuster HIV treatment Tivicay (dolutegravir) has been approved by the European Commission. ... An integrase inhibitor, Tivicay works by blocking

FDA clears Isentress formulation for infants with HIV

FDA clears Isentress formulation for infants with HIV Tivicay (dolutegravir)  – a fellow integrase inhibitor developed by the GlaxoSmithKline/Pfizer/Shionogi joint venture ViiV Healthcare – was approved in the US in combination with other antiretroviral agents to treat patients aged ... Studies have

ViiV's Tivicay for HIV on course for EU approval

ViiV's Tivicay for HIV on course for EU approval More positive news for GSK, Pfizer and Shionogi joint venture. ViiV Healthcare's new HIV treatment Tivicay has been recommended for approval in the EU, a few weeks after making a ... Tivicay is an HIV integrase inhibitor and blocks replication of the

[ Previous 5 results ] 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics